Our TgVil1-Itln1 model represents a gut-specific gain of function model that closely mimics the expression pattern of ITLN1 in the human colon and IBD (Wang et al., 2020; Nonnecke et al., 2021; Nonnecke et al., 2022). Here, ITLN1 is linked to inflammatory bowel disease.